Victory Capital Management Inc Oncternal Therapeutics, Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$2.43 - $3.23 $4,979 - $6,618	-2,049 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.49 - $4.39 $283 - $500	114 Added 5.89%	2,049 $6,000
Q4 2019 Feb 04, 2020	BUY	$3.75 - $6.11 $5,505 - $8,969	1,468 Added 314.35%	1,935 $7,000
Q3 2019 Nov 12, 2019	BUY	$3.87 - $6.13 $1,807 - $2,862	467 New	467 $2,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $41.6M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.